Dog Vaccine Market to Grow with a CAGR of 5.75% through 2029
Increasing prevalence of canine diseases is expected to drive the Global Dog Vaccine Market growth in the forecast period, 2025-2029
According to
TechSci Research report, “Dog Vaccine Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029F”, the Global Dog
Vaccine Market stood at USD 1.45 Billion in 2023 and is anticipated to grow
with a CAGR of 5.75% in the forecast period, 2025-2029. The prevalence of
canine diseases such as rabies, parvovirus, distemper, and canine influenza
remains a significant concern for pet owners and veterinarians worldwide. These
diseases pose serious health risks to dogs and can spread rapidly within the
canine population. As a result, there is a growing emphasis on preventive
healthcare strategies, including vaccination, to control the spread of these
diseases and protect dogs from illness and death. The rising incidence of these
diseases is driving the demand for dog vaccines globally.
Governments
around the world have implemented stringent regulations mandating the
vaccination of dogs against certain diseases. These regulations are aimed at
controlling outbreaks, preventing the spread of infectious diseases, and
safeguarding public health. Compliance with these regulations is essential for
pet owners, and failure to vaccinate their dogs may result in legal
consequences. As a result, the demand for dog vaccines is driven by the need to
adhere to government-mandated vaccination schedules and requirements.
Advancements in
veterinary medicine and biotechnology have led to the development of more
efficacious and safer vaccines for dogs. These advancements have resulted in
vaccines that offer improved protection against a broader range of diseases,
longer duration of immunity, and reduced risk of adverse reactions.
Additionally, novel vaccine delivery technologies such as DNA vaccines,
recombinant vaccines, and oral vaccines are revolutionizing the landscape,
offering pet owners and veterinarians innovative solutions for protecting dogs'
health. Moreover, the companion animal healthcare sector is experiencing rapid
growth, driven by increasing pet ownership rates and growing awareness of pet
health and wellness.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Dog Vaccine Market”
The Global Dog
Vaccine Market is segmented into type, disease type, route of administration, component, regional distribution, and company
Based on
the route of administration, oral segment emerged as the dominant segment in
the global dog vaccine market in 2023. Oral
vaccines are generally easier to administer compared to injectable vaccines,
especially for dogs. Dogs may be more cooperative with an oral dose compared to
receiving an injection, which can be stressful for both the dog and the owner. Many
dog owners prefer oral vaccines because they eliminate the need for needles.
This can reduce anxiety and discomfort for both the dog and the owner during
the vaccination process. Oral vaccines are perceived as safer and more
convenient by pet owners. They eliminate the risk of accidental needle sticks
and can be administered quickly and efficiently. Advances in vaccine technology
have led to the development of effective oral vaccines for dogs. These vaccines
are designed to be stable in the gastrointestinal tract and capable of
eliciting a strong immune response. The ease of administering oral vaccines may
lead to higher compliance rates among dog owners. This means more dogs receive
timely vaccinations, which is crucial for preventing the spread of infectious
diseases.
Asia
Pacific emerged as the fastest growing region in the global dog vaccine
market in 2023.
There has been a notable rise in pet ownership across many
countries in the Asia Pacific region. As more households embrace dogs as
companion animals, the demand for veterinary services, including vaccinations,
has surged. Pet owners in Asia Pacific are becoming more aware of the
importance of preventive healthcare for their pets. Vaccination is seen as a
crucial aspect of keeping dogs healthy and protected from various infectious
diseases. Many governments and animal welfare organizations in the Asia Pacific
region are actively promoting responsible pet ownership and offering
vaccination programs at subsidized rates or for free. This has contributed to
higher vaccination rates. Economic growth in several countries within the Asia
Pacific region has led to higher disposable incomes among households. This has
allowed more families to afford veterinary services, including vaccinations,
for their pets.
Major companies
operating in Global Dog Vaccine Market are:
- Bioveta A.S
- Hester Biosciences Limited
- Boehringer Ingelheim International GmbH
- Brilliant Bio Pharma Private Limited
- Heska Corporation
- Merck & Co., Inc.
- Virbac SACA
- Zendal Group
- Elanco Animal Health Inc.
- Zoetis Services LLC
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The
Global Dog Vaccine Market is poised for significant growth in the coming years.
Rising pet ownership rates worldwide, coupled with increasing awareness of the
importance of preventive healthcare measures, are expected to drive demand for
dog vaccines. Additionally, the growing prevalence of canine diseases and
stringent government regulations mandating vaccination are likely to contribute
to market expansion. Advancements in veterinary medicine and biotechnology,
particularly in the development of more efficacious and safer vaccines, are
further expected to stimulate market growth. Moreover, the expanding companion
animal healthcare sector, alongside rising disposable income levels in emerging
economies, presents significant opportunities for market players to capitalize
on”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Dog Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Modified/ Attenuated Live, Inactivated (Killed), Others), By Disease Type (Canine Distemper, Canine Infectious Respiratory Disease, Complex (CIRDC), Canine Parvoviruses/ Parvovirus Disease, Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine Rabies, Other Diseases), By Route of Administration (Injectable, Intranasal, Oral), By Component (Combined Vaccines, Mono Vaccines) Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Dog Vaccine Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Dog Vaccine Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com